Lucia Magnelli
Overview
Explore the profile of Lucia Magnelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
661
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peppicelli S, Calorini L, Bianchini F, Papucci L, Magnelli L, Andreucci E
Cell Oncol (Dordr)
. 2024 Jul;
48(1):27-41.
PMID: 39023664
The complex and continuously evolving features of the tumor microenvironment, varying between tumor histotypes, are characterized by the presence of host cells and tumor cells embedded in a milieu shaped...
2.
Lulli M, Tartaro R, Papucci L, Magnelli L, Kaur I, Caporossi T, et al.
Mol Biol Rep
. 2024 Jun;
51(1):746.
PMID: 38874663
Background: Human Amniotic Membrane (hAM) is endowed with several biological activities and might be considered an optimal tool in surgical treatment for different ophthalmic pathologies. We pioneered the surgical use...
3.
Cecchi M, Anceschi C, Silvano A, Coniglio M, Chinnici A, Magnelli L, et al.
Pharmaceuticals (Basel)
. 2024 May;
17(5).
PMID: 38794128
Background: Indoleamine 2,3-dioxygenase (IDO1) and tryptophan-2,3-dioxygenase (TDO) are the two principals enzymes involved in the catabolization of tryptophan (Trp) into kynurenine (Kyn). Despite their well-established role in the immune escape,...
4.
Andreucci E, Biagioni A, Peri S, Versienti G, Cianchi F, Staderini F, et al.
Cancer Lett
. 2023 Aug;
571:216338.
PMID: 37549770
Gastric cancer (GC) is the fifth most frequent malignancy and the fourth leading cause of worldwide cancer-related death. Despite the usage of multimodal perioperative chemotherapy (pCT), GC progressively gains chemoresistance,...
5.
Biagioni A, Peri S, Versienti G, Fiorillo C, Becatti M, Magnelli L, et al.
Biomolecules
. 2023 Jun;
13(6).
PMID: 37371466
Blood vessels are the most important way for cancer cells to survive and diffuse in the body, metastasizing distant organs. During the process of tumor expansion, the neoplastic mass progressively...
6.
Peri S, Ruzzolini J, Urciuoli S, Versienti G, Biagioni A, Andreucci E, et al.
Antioxidants (Basel)
. 2022 Sep;
11(9).
PMID: 36139836
Oleocanthal, a minor polar compound in extra-virgin olive (EVO) oil, contains anticancer properties, which should be encouraged in its use in oncology. Gastric Cancer (GC), a very aggressive human cancer,...
7.
Tortora K, Margheri F, Luceri C, Mocali A, Ristori S, Magnelli L, et al.
Int J Cancer
. 2021 Sep;
150(2):362-373.
PMID: 34486752
The role of fibroblast APC mutation in carcinogenesis is not clear. Apc colon fibroblasts have been previously characterized: however, little is known about their behavior at very early-stage of colon...
8.
Peri S, Biagioni A, Versienti G, Andreucci E, Staderini F, Barbato G, et al.
Int J Mol Sci
. 2021 Jul;
22(14).
PMID: 34299320
Chemotherapy is still widely used as a coadjutant in gastric cancer when surgery is not possible or in presence of metastasis. During tumor evolution, gatekeeper mutations provide a selective growth...
9.
Biagioni A, Tavakol S, Ahmadirad N, Zahmatkeshan M, Magnelli L, Mandegary A, et al.
IUBMB Life
. 2021 May;
73(6):825-842.
PMID: 33938625
The small nucleolar RNA host genes (SNHGs) belong to the long non-coding RNAs and are reported to be able to influence all three levels of cellular information-bearing molecules, that is,...
10.
Biagioni A, Staderini F, Peri S, Versienti G, Schiavone N, Cianchi F, et al.
Biology (Basel)
. 2020 Sep;
9(9).
PMID: 32887417
To date, 5-Fluorouracil (5FU) is a major component of several chemotherapy regimens, thus its study is of fundamental importance to better understand all the causes that may lead to chemoresistance...